2020 ISPE Europe Pharma 4.0 Virtual Conference

Nov 17, 2020 ‐ Nov 18, 2020

Welcome to 2020 ISPE Pharma 4.0 Virtual Conference

Preview Available

Welcome to 2020 ISPE Pharma 4.0 Virtual Conference

Nov 17, 2020 8:00am ‐ Nov 17, 2020 8:15am

Identification: EU20CENOV1/SESKN01

Welcome to 2020 ISPE Pharma 4.0 Virtual Conference |

• Christian Wölbeling, Executive Industry Advisor, Körber Pharma Software

A Vision of Pharma 4.0 Operations

Preview Available

A Vision of Pharma 4.0 Operations

Nov 17, 2020 8:15am ‐ Nov 17, 2020 8:45am

Identification: EU20CENOV1/SESKN02

A Vision of Pharma 4.0 Operations |

• Amit Nastik, Head NTO Global Strategy, Operations and Local Markets Manufacturing, Novartis Technical Operations

Boost and Sustain Performance for Tomorrow

Preview Available

Boost and Sustain Performance for Tomorrow

Nov 17, 2020 8:45am ‐ Nov 17, 2020 9:15am

Identification: EU20CENOV1/SESKN03

Boost and Sustain Performance for Tomorrow |

• Maria Teresa Rodo Cima, PhD, EVP Global Healthcare Operations, Merck Healthcare KGaA

Joining Forces: Driving Digitalization for Pharma Manufacturing

Preview Available

Joining Forces: Driving Digitalization for Pharma Manufacturing

Nov 17, 2020 9:45am ‐ Nov 17, 2020 10:15am

Identification: EU20CENOV1/SESKN04

Joining Forces: Driving Digitalization for Pharma Manufacturing |

• James Thomas, Head of Digital Strategy, Bayer AG

Lilly's Perspective on Future Operations in the New Era of Digitisation and AI

Preview Available

Lilly's Perspective on Future Operations in the New Era of Digitisation and AI

Nov 17, 2020 10:15am ‐ Nov 17, 2020 10:45am

Identification: EU20CENOV1/SESKN05

Lilly's Perspective on Future Operations in the New Era of Digitisation and AI |

• David S. Sternasty, Vice President, Corporate Engineering, Eli Lilly and Company

Connected Health - World after COVID - Digital Therapeutics

Preview Available

Connected Health - World after COVID - Digital Therapeutics

Nov 17, 2020 10:45am ‐ Nov 17, 2020 11:00am

Identification: EU20CENOV1/SESKN06

Connected Health - World after COVID - Digital Therapeutics |

• Giuseppe Recchia, Co-Founder & CEO, DaVinci Digital Therapeutics

Artificial Intelligence for Connected Health Post-Covid: Technical and Ethical Challenges

Preview Available

Artificial Intelligence for Connected Health Post-Covid: Technical and Ethical Challenges

Nov 17, 2020 11:00am ‐ Nov 17, 2020 11:15am

Identification: EU20CENOV1/SESKN06B

Artificial Intelligence for Connected Health Post-Covid: Technical and Ethical Challenges |

• Barry O'Sullivan, Professor, School of Computer Science & IT, University College Cork, Ireland

Panel Discussion with Speakers from the Track "Pharma 4.0 Vision"

Preview Available

Panel Discussion with Speakers from the Track "Pharma 4.0 Vision"

Nov 17, 2020 11:15am ‐ Nov 17, 2020 12:00pm

Identification: EU20CENOV1/SESKN07

Panel Discussion with Speakers from the Track "Pharma 4.0 Vision" |

• Maria Teresa Rodo Cima, PhD, EVP Global Healthcare Operations, Merck Healthcare KGaA
• Giuseppe Recchia, Co-Founder & CEO, DaVinci Digital Therapeutics
• David S. Sternasty, Vice President, Corporate Engineering, Eli Lilly and Company
• Amit Nastik, Head NTO Global Strategy, Operations and Local Markets Manufacturing, Novartis Technical Operations
• Barry O'Sullivan, Professor, School of Computer Science & IT, University College Cork, Ireland
• James Thomas, Head of Digital Strategy, Bayer AG
• Christian Wölbeling, Executive Industry Advisor, Körber Pharma Software

"My Life in Quality 4.0": Let's Imagine Pharma 4.0 in Real Life, What Would My Day-to-Day Business Look Like

Preview Available

"My Life in Quality 4.0": Let's Imagine Pharma 4.0 in Real Life, What Would My Day-to-Day Business Look Like

Nov 17, 2020 1:00pm ‐ Nov 17, 2020 1:25pm

Identification: EU20CENOV1/SES101

"My Life in Quality 4.0": Let's Imagine Pharma 4.0 in Real Life, What Would My Day-to-Day Business Look Like |

• Heike Roeder, Lead Digital Transformation QMS, Bayer AG

FAIR Data for Better Patient Outcomes

Preview Available

FAIR Data for Better Patient Outcomes

Nov 17, 2020 1:25pm ‐ Nov 17, 2020 1:45pm

Identification: EU20CENOV1/SES102

FAIR Data for Better Patient Outcomes |

• Alexandra Grebe De Barron, Data Product Owner in Digital Transformation & IT, Bayer AG